Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Authors: Maud Mayoux, Andreas Roller, Vesna Pulko, Stefano Sammicheli, Stanford Chen, Eva Sum, Christian Jost, Marieke F. Fransen, Regula B. Buser, Marcin Kowanetz, Karolin Rommel, Ines Matos, Sara Colombetti, Anton Belousov, Vaios Karanikas, Ferry Ossendorp, Priti S. Hegde, Daniel S. Chen, Pablo Umana, Mario Perro, Christian Klein, Wei Xu

Published: 2020-03-11

DOI: 10.1126/scitranslmed.aav7431

Source: Full article


Abstract

DCs are critical cellular targets of PD-L1 blockade in cancer treatment.